These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25843759)

  • 21. Vancomycin storage stability in multilayer thin film coatings for on-demand care.
    Shukla A; Puranam S; Hammond PT
    J Biomater Sci Polym Ed; 2012; 23(15):1895-902. PubMed ID: 21944195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclodextrin-mesoporous silica particle composites for controlled antibiotic release. A proof of concept toward colon targeting.
    Stjern L; Voittonen S; Weldemichel R; Thuresson S; Agnes M; Benkovics G; Fenyvesi É; Malanga M; Yannakopoulou K; Feiler A; Valetti S
    Int J Pharm; 2017 Oct; 531(2):595-605. PubMed ID: 28554545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrical signals guided entrapment and controlled release of antibiotics on titanium surface.
    Shi X; Wu H; Li Y; Wei X; Du Y
    J Biomed Mater Res A; 2013 May; 101(5):1373-8. PubMed ID: 23077102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro controlled release of antihypertensive drugs intercalated into unmodified SBA-15 and MgO modified SBA-15 matrices.
    Alexa IF; Ignat M; Popovici RF; Timpu D; Popovici E
    Int J Pharm; 2012 Oct; 436(1-2):111-9. PubMed ID: 22743006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent antibacterial nanoparticles for pathogenic bacteria.
    Lai HZ; Chen WY; Wu CY; Chen YC
    ACS Appl Mater Interfaces; 2015 Jan; 7(3):2046-54. PubMed ID: 25584802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NanoKeepers: stimuli responsive nanocapsules for programmed specific targeting and drug delivery.
    Hernandez FJ; Hernandez LI; Kavruk M; Arıca YM; Bayramoğlu G; Borsa BA; Öktem HA; Schäfer T; Özalp VC
    Chem Commun (Camb); 2014 Aug; 50(67):9489-92. PubMed ID: 25008577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo tissue response to resorbable silica xerogels as controlled-release materials.
    Radin S; El-Bassyouni G; Vresilovic EJ; Schepers E; Ducheyne P
    Biomaterials; 2005 Mar; 26(9):1043-52. PubMed ID: 15369693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activity and biocompatibility of slow-release hyaluronic acid-antibiotic conjugated particles.
    Zhang Z; Suner SS; Blake DA; Ayyala RS; Sahiner N
    Int J Pharm; 2020 Feb; 576():119024. PubMed ID: 31926974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of ampicillin-conjugated gum arabic microspheres for sustained release.
    Nishi KK; Antony M; Jayakrishnan A
    J Pharm Pharmacol; 2007 Apr; 59(4):485-93. PubMed ID: 17430631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesoporous silica nanoparticles as a new carrier methodology in the controlled release of the active components in a polypill.
    Doadrio AL; Sánchez-Montero JM; Doadrio JC; Salinas AJ; Vallet-Regí M
    Eur J Pharm Sci; 2017 Jan; 97():1-8. PubMed ID: 27818251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity.
    Zhu CT; Xu YQ; Shi J; Li J; Ding J
    Drug Deliv; 2010 Aug; 17(6):391-8. PubMed ID: 20429845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic-sensitive silica nanospheres for controlled drug release.
    Hu SH; Liu TY; Huang HY; Liu DM; Chen SY
    Langmuir; 2008 Jan; 24(1):239-44. PubMed ID: 18052081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silicon oxide based materials for controlled release in orthopedic procedures.
    Qu H; Bhattacharyya S; Ducheyne P
    Adv Drug Deliv Rev; 2015 Nov; 94():96-115. PubMed ID: 26032046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue engineering scaffold for sequential release of vancomycin and rhBMP2 to treat bone infections.
    Pacheco H; Vedantham K; Aniket ; Young A; Marriott I; El-Ghannam A
    J Biomed Mater Res A; 2014 Dec; 102(12):4213-23. PubMed ID: 24446113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced efficacy and broadening of antibacterial action of drugs via the use of capped mesoporous nanoparticles.
    Mas N; Galiana I; Mondragón L; Aznar E; Climent E; Cabedo N; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
    Chemistry; 2013 Aug; 19(34):11167-71. PubMed ID: 23839913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silk coating on poly(ε-caprolactone) microspheres for the delayed release of vancomycin.
    Zhou J; Fang T; Wen J; Shao Z; Dong J
    J Microencapsul; 2011; 28(2):99-107. PubMed ID: 21265711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesostructured silica and aluminosilicate carriers for oxytetracycline delivery systems.
    Berger D; Nastase S; Mitran RA; Petrescu M; Vasile E; Matei C; Negreanu-Pirjol T
    Int J Pharm; 2016 Aug; 510(2):524-31. PubMed ID: 26861688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesoporous silica pellets as bifunctional bone drug delivery system for cefazolin.
    Szewczyk A; Skwira A; Konopacka A; Sądej R; Walker G; Prokopowicz M
    Int J Pharm; 2020 Oct; 588():119718. PubMed ID: 32750441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailoring vancomycin release from beta-TCP/agarose scaffolds.
    Cabañas MV; Peña J; Román J; Vallet-Regí M
    Eur J Pharm Sci; 2009 Jun; 37(3-4):249-56. PubMed ID: 19491012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silica microparticles for sustained zero-order release of an anti-CD40L antibody.
    Tyagi P; Koskinen M; Mikkola J; Leino L; Schwarz A
    Drug Deliv Transl Res; 2018 Apr; 8(2):368-374. PubMed ID: 28752299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.